Apotex Health Corp. (TSX:APTX)
Canada flag Canada · Delayed Price · Currency is CAD
31.87
-0.50 (-1.54%)
At close: Aug 28, 2026

Apotex Health Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingJun '26 Mar '26 Mar '25 Mar '24
Revenue
3,1973,4913,3502,940
Revenue Growth
-4.21%13.92%-
Gross Profit
1,6201,9431,8201,322
Operating Income
633.831,070997.98628.71
Net Income
-27.27373.78151.7-146.92
Earnings Per Share
-0.161.910.80-0.82
EPS Growth
-139.14%--

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingJun '26 Mar '26 Mar '25 Mar '24
Conventional Generics
1,5331,7811,8721,786
Specialty Generics
1,0931,151976.3784.21
Brands & Biosimilars
570.31558.7500.96369.76
Total
3,1973,4913,3502,940

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingJun '26 Mar '26 Mar '25 Mar '24
Cash & Investments
258.7656.9977.97421.35
Total Debt
3,0223,5212,6501,874
Net Cash (Debt)
-2,764-3,464-2,572-1,452
Net Cash Growth
----
Net Cash Per Share
-14.17-17.94-13.56-8.12

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingJun '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
263.66640.96554.41570.9
Capital Expenditures
-139.41-121.06-93.58-83.26
Free Cash Flow
124.25519.9460.84487.65
Free Cash Flow Growth
-12.82%-5.50%-

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingJun '26 Mar '26 Mar '25 Mar '24
Gross Margin
50.69%55.65%54.34%44.97%
Operating Margin
19.83%30.65%29.79%21.38%
Pretax Margin
1.48%14.89%9.27%-5.29%
Profit Margin
-0.85%10.71%4.53%-5.00%
FCF Margin
3.89%14.89%13.76%16.58%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingAug '26 Mar '26 Mar '25 Mar '24
Dividend Per Share
0.200-6.4795.059
Dividend Per Share Growth
0%-28.05%-